Nationwide surveillance shows increased incidence and recurrence of Clostridioides difficile in patients, highlighting key public health concerns.
Background Clostridioides difficile infection (CDI) is a significant contributor to healthcare-associated infections worldwide, with an increasing incidence in Europe. It has significant morbidity in high-risk, hospitalized patients. Despite previous studies in Spain, there have been no updates to nationwide data since 2015.
No takes yet. Share an insight, caveat, or question.
Carretero et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: